CARTHERA

Carthera® is a spin-off from AP-HP, Greater Paris University Hospitals, the largest hospital group in Europe, and Sorbonne University. The company leverages the inventions of Professor Alexandre Carpentier, lead neurosurgeon at AP-HP, who has achieved worldwide recognition for his breakthrough developments in treating brain tumors... Founded in 2010, Carthera® is headquartered in Lyon. The company also has offices at the Brain Institute (Institut du Cerveau, ICM) in Paris and a US subsidiary based in Boston. It works closely with renowned academic institutions, like INSERM, Sorbonne University, AP-HP, Northwestern University, UCSF... Carthera® is a clinical-stage company with its SonoCloud® implant that temporarily opens the blood-brain barrier (BBB). SonoCloud® is presently being investigated in several clinical trials in oncology as well as in neurodegenerative diseases.

Also known as: Carthera Incorporated, Carthera S.A.

VAT numbers: FR81 520 004 607

Primary location: Lyon France